Vaccination of Macaques with Adjuvanted Formalin-Inactivated Influenza A Virus (H5N1) Vaccines: Protection against H5N1 Challenge without Disease Enhancement

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Journal of Virology

• Publication date

  2007-12-19

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1128/JVI.01928-07PMID 18094159PMCID PMC2258952
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Aberrant innate immune response in lethal infection of macaques with the 1918 influenza virus

  2007cited by this paper
• H5N1 Viruses and Vaccines

  2007cited by this paper
• Cross-protectiveness and immunogenicity of influenza A/Duck/Singapore/3/97(H5) vaccines against infection with A/Vietnam/1203/04(H5N1) virus in ferrets.

  2006cited by this paper
• Immunization with reverse-genetics-produced H5N1 influenza vaccine protects ferrets against homologous and heterologous challenge.

  2006cited by this paper
• Live, Attenuated Influenza A H5N1 Candidate Vaccines Provide Broad Cross-Protection in Mice and Ferrets

  2006cited by this paper
• Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia

  2006cited by this paper
• Oseltamivir resistance during treatment of influenza A (H5N1) infection.

  2005cited by this paper
• Pathology of Human Influenza A (H5N1) Virus Infection in Cynomolgus Macaques (Macaca fascicularis)

  2003cited by this paper
• Immunization of Macaques with Formalin-Inactivated Respiratory Syncytial Virus (RSV) Induces Interleukin-13-Associated Hypersensitivity to Subsequent RSV Infection

  2002cited by this paper
• Immunopathogenesis of vaccine-enhanced RSV disease.

  2001cited by this paper
• Pathogenesis of Influenza A (H5N1) Virus Infection in a Primate Model

  2001cited by this paper
• Detection of Antibody to Avian Influenza A (H5N1) Virus in Human Serum by Using a Combination of Serologic Assays

  1999cited by this paper
• Viral replication and development of specific immunity in macaques after infection with different measles virus strains.

  1994cited by this paper

• Translational research on pandemic virus infection using nonhuman primate models.

  2025cites this paper
• Research progress on emulsion vaccine adjuvants

  2024cites this paper
• The evolution of H5N1 influenza viruses in Indonesia to mammalian hosts: a review of molecular markers

  2024cites this paper
• Pandemic preparedness through vaccine development for avian influenza viruses

  2024cites this paper
• Aerosolized Exposure to H5N1 Influenza Virus Causes Less Severe Disease Than Infection via Combined Intrabronchial, Oral, and Nasal Inoculation in Cynomolgus Macaques

  2021cites this paper
• Comparative Safety and Efficacy Profile of a Novel Oil in Water Vaccine Adjuvant Comprising Vitamins A and E and a Catechin in Protective Anti-Influenza Immunity

  2017cites this paper
• The avian influenza vaccine Emerflu. Why did it fail?

  2015cites this paper
• The use of nonhuman primates in research on seasonal, pandemic and avian influenza, 1893-2014.

  2015cites this paper
• Vaccine technologies against avian influenza: current approaches and new directions.

  2014cites this paper
• Animal models in virus research: their utility and limitations

  2013cites this paper
• H5N1 pathogenesis studies in mammalian models.

  2013influential citation
• H5N1 vaccines in humans.

  2013cites this paper
• Immunogenicity and protective efficacy of cold-adapted X-31 live attenuated pre-pandemic H5N1 influenza vaccines.

  2013cites this paper
• Synthetic nanoparticle-based vaccines against respiratory pathogens

  2013cites this paper
• Immunogenic and protective properties of the first kazakhstan vaccine against pandemic influenza A (H1N1) pdm09 in Ferrets

  2012cites this paper
• AF03, an alternative squalene emulsion-based vaccine adjuvant prepared by a phase inversion temperature method.

  2012cites this paper
• Cross-Reactive T Cells Are Involved in Rapid Clearance of 2009 Pandemic H1N1 Influenza Virus in Nonhuman Primates

  2011cites this paper
• Delta inulin polysaccharide adjuvant enhances the ability of split-virion H5N1 vaccine to protect against lethal challenge in ferrets.

  2011cites this paper
• CD154 expression is associated with neutralizing antibody titer levels postinfluenza vaccination in stem cell transplant patients and healthy adults.

  2011cites this paper
• Enhanced Immunogenicity, Mortality Protection, and Reduced Viral Brain Invasion by Alum Adjuvant with an H5N1 Split-Virion Vaccine in the Ferret

  2011cites this paper
• Proteomic characterization of influenza H5N1 virus-like particles and their protective immunogenicity.

  2011cites this paper
• Animal models for the preclinical evaluation of candidate influenza vaccines

  2010cites this paper
• Reverse micelle-encapsulated recombinant baculovirus as an oral vaccine against H5N1 infection in mice.

  2010cites this paper
• Dogs are highly susceptible to H 5 N 1 avian in fl uenza virus

  2010cites this paper
• Cross-clade immunity in cats vaccinated with a canarypox-vectored avian influenza vaccine.

  2010cites this paper
• Dogs are highly susceptible to H5N1 avian influenza virus.

  2010cites this paper
• In process quality control factors affecting efficacy of Avian Influenza (H5N1) vaccine.

  2010cites this paper
• MVA-Based H5N1 Vaccine Affords Cross-Clade Protection in Mice against Influenza A/H5N1 Viruses at Low Doses and after Single Immunization

  2009cites this paper
• Recombinant modified vaccinia virus Ankara expressing the hemagglutinin gene confers protection against homologous and heterologous H5N1 influenza virus infections in macaques.

  2009cites this paper
• Immunogenicity and Protective Efficacy of a Live Attenuated H5N1 Vaccine in Nonhuman Primates

  2009cites this paper
• Measles Studies in the Macaque Model

  2009cites this paper
• Superior efficacy of a recombinant flagellin:H5N1 HA globular head vaccine is determined by the placement of the globular head within flagellin.

  2009cites this paper
• Vaccination strategies and vaccine formulations for epidemic and pandemic influenza control

  2009cites this paper
• Electroporation of Synthetic DNA Antigens Offers Protection in Nonhuman Primates Challenged with Highly Pathogenic Avian Influenza Virus

  2009cites this paper
• Vaccines for pandemic influenza: summary of recent clinical trials.

  2009cites this paper
• Animal models for the study of influenza pathogenesis and therapy

  2009cites this paper
• Adjuvants for pandemic influenza vaccines.

  2009cites this paper
• Induction of Long-Term Protective Immune Responses by Influenza H5N1 Virus-Like Particles

  2009cites this paper
• Emulsion-based adjuvants for influenza vaccines

  2009cites this paper
• Current status and progress of prepandemic and pandemic influenza vaccine development

  2009cites this paper
• A cell‐based H7N1 split influenza virion vaccine confers protection in mouse and ferret challenge models

  2009cites this paper
• Cross-clade protective immunity of H5N1 influenza vaccines in a mouse model.

  2008cites this paper
• Correlates of protection: novel generations of influenza vaccines.

  2008cites this paper
• Animal models in influenza vaccine testing

  2008cites this paper
• Improving seasonal and pandemic influenza vaccines

  2008cites this paper